Lungs News and Research

RSS

H5N1 avian influenza found in stranded harbor porpoise

In a recent study published in the United States (U.S.) Centers for Disease Control and Prevention (CDC) journal Emerging Infectious Diseases, researchers from Sweden described the detection of the hemagglutinin type 5 and neuraminidase type 1 (H5N1) avian influenza virus in a stranded harbor porpoise, indicating a potential spillover of this highly pathogenic avian influenza virus into cetacean species.

20 Mar 2023

What role does dysbiosis play in Parkinson's disease?

The current study, published in the journal Revue Neurologique, is based on the hypothesis that dysbiosis, or unhealthy variations in the gut and oral microbiota, is a key component of PD pathogenesis.

19 Mar 2023

Study reveals the underlying mechanism by which TKI cancer drugs cause inflammation

Tyrosine kinase inhibitors are a type of targeted cancer medicine that can attack specific types of cancer cells and prevent them from multiplying.

17 Mar 2023

Stanford researchers study causes of and treatments for long COVID

Time heals many wounds. But not all of them.

17 Mar 2023

Study suggests a novel strategy to combat multidrug-resistant S. pneumoniae infections

Pneumococcal disease leads to over three million hospitalizations and hundreds of thousands of deaths annually.

17 Mar 2023

Research highlights the potential risk of secondary SARS-CoV-2 transmission from wild rats

In a recent study published in the journal mBio, researchers in the United States evaluated rat exposure to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in New York City (NYC).

16 Mar 2023

Study demonstrates long-term safety and clinical benefit of combination therapy for cystic fibrosis

Patients with cystic fibrosis (CF) face difficulty breathing and a decline in lung function and are at risk of early death. CF is an inherited condition that results in thick mucus build-up, persistent infection and inflammation in the lungs.

15 Mar 2023

Scientists find a good treatment target for pulmonary hypertension

The vascular smooth muscle cells that normally give blood vessel walls strength and flexibility proliferate and become destructive in pulmonary hypertension, a typically rapidly progressing condition that makes it hard to get blood inside our lungs and oxygen to our bodies.

14 Mar 2023

Black lung resurgence drives push to protect coal miners against silica dust

Like most coal miners' loved ones, Liz Williams has endured many days and nights of worry.

14 Mar 2023

How does temperature affect host responses to SARS-CoV-2 and IAV infection in human nasal epithelial cells?

A new preprint examines the response to these pathogens in the nose, which is the primary portal of entry for both.

13 Mar 2023

Research reveals the mechanism that triggers breast cancer 'time bomb'

Scientists have discovered why breast cancer cells that have spread to the lungs may 'wake up' following years of sleep - forming incurable secondary tumors.

13 Mar 2023

SARS-CoV-2 replication persists for weeks in lungs after symptom onset in severe COVID-19

Researchers observe persistent SARS-CoV-2 replication in severe COVID-19 patient lungs.

13 Mar 2023

Study: Black patients with pulmonary fibrosis are younger than Hispanic and white counterparts

Pulmonary fibrosis is a devastating disease characterized by progressive scarring in the lungs, killing up to half of patients within five years of a diagnosis.

10 Mar 2023

Innovative breathing device offers promise for improving the lives of people with COPD

One in 10 adults suffer from the debilitating effects of chronic obstructive pulmonary disease (COPD). Research around a new breathing device developed by pulmonologists at the University of Cincinnati offers promise for improving their lives.

10 Mar 2023

Healthy gut bacteria can travel to other parts of the body and boost antitumor immunity

Researchers at UT Southwestern Medical Center have discovered how healthy bacteria can escape the intestine, travel to lymph nodes and cancerous tumors elsewhere in the body, and boost the effectiveness of certain immunotherapy drugs.

9 Mar 2023

COVID-19 patients at increased risk of developing gastrointestinal disorders

People who have had COVID-19 are at increased risk of developing gastrointestinal (GI) disorders within a year after infection compared with people who haven't been infected, according to an analysis of federal health data by researchers at Washington University School of Medicine in St. Louis and the Veterans Affairs St. Louis Health Care system.

8 Mar 2023

Lungs News and Research

H5N1 avian influenza found in stranded harbor porpoise

What role does dysbiosis play in Parkinson's disease?

Study reveals the underlying mechanism by which TKI cancer drugs cause inflammation

Stanford researchers study causes of and treatments for long COVID

Study suggests a novel strategy to combat multidrug-resistant S. pneumoniae infections

Research highlights the potential risk of secondary SARS-CoV-2 transmission from wild rats

Study demonstrates long-term safety and clinical benefit of combination therapy for cystic fibrosis

Scientists find a good treatment target for pulmonary hypertension

Black lung resurgence drives push to protect coal miners against silica dust

How does temperature affect host responses to SARS-CoV-2 and IAV infection in human nasal epithelial cells?

Research reveals the mechanism that triggers breast cancer 'time bomb'

SARS-CoV-2 replication persists for weeks in lungs after symptom onset in severe COVID-19

Study: Black patients with pulmonary fibrosis are younger than Hispanic and white counterparts

Innovative breathing device offers promise for improving the lives of people with COPD

Healthy gut bacteria can travel to other parts of the body and boost antitumor immunity

COVID-19 patients at increased risk of developing gastrointestinal disorders

Study illuminates how the brain senses infection

Breakthrough drug works against all the main types of primary bone cancer

Self-directed autoantibodies against certain chemokines may protect against long-COVID

Deceased SARS-CoV-2-infected individuals may be a potential source of virus, research shows

The ultimate guide to lung research tools and protocols eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News